Replacement heart valves made by Edwards Lifesciences and Medtronic once again dominate the American College of Cardiology's annual meeting, with long-term results for Edwards' Sapien and Medtronic's CoreValve complemented by even better data from their next-generation transcatheter aortic valve implants.
Transcatheter aortic valve implants once again took the spotlight at the annual meeting of the American College of Cardiology, with a spate of studies both confirming the long-term benefits of the replacement heart valves and showing that newer TAVI versions are even better.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EjGwYj
Cap comentari:
Publica un comentari a l'entrada